Published in

Elsevier España, Hipertensión y Riesgo Vascular, 4(29), p. 156-158

DOI: 10.1016/j.hipert.2012.07.004

Links

Tools

Export citation

Search in Google Scholar

El uso de nuevas técnicas para el diagnóstico de recidiva del feocromocitoma

Journal article published in 2012 by L. Rivera Zambrano, J. Reyes, F. Calero, J. Ballarín, P. Fernández Llama ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Pheochromocytoma is a catecholamine-secreting tumor derived from chromaffin cells of the adrenal medulla and extra-adrenal sympathetic and parasympathetic tissue. Diagnosis should be made by hormonal tests and supplemented with imaging techniques such as tomography (CT) and/or magnetic resonance imaging (MR). To confirm its location and the existence of multiple tumors, it is necessary to perform a functional test, the iodo-methyl-benzylguanidine (IMBG) scintigraphy being the test of choice. Its sensitivity decreases in extra-adrenal location pheochromocytomas or malignant tumors. Two cases are reported in which, despite high clinical suspicion of recurrence of pheochromocytoma, the IMBG scintigraphy was negative. The positron emission tomography (PET-CT) using 18-fluorodeoxyglucose (18F-FDG) was essential for the diagnosis in both cases. In addition, the need for a genetic study in some cases of non-syndromic pheochromocytoma is discussed.